p54nrb is a new regulator of progression of malignant melanoma

Susanne Schiffner1, Nicole Zimara, Rainer Schmid

  • 1Institute of Pathology, Molecular Pathology, University of Regensburg Medical School, Regensburg, Germany.

Carcinogenesis
|June 7, 2011
PubMed

Insights

Nuclear RNA-binding protein p54(nrb) is highly expressed in melanoma and regulates cell proliferation and migration. Melanoma inhibitory activity (MIA) influences p54(nrb) expression, suggesting a role in melanoma development.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Nuclear RNA-binding protein p54(nrb) (also known as NonO) participates in nuclear processes like transcription and RNA processing.
  • Melanoma inhibitory activity (MIA) is crucial for malignant melanoma progression and influences early tumor formation pathways.
  • Emerging evidence suggests MIA regulates p54(nrb).

Purpose of the Study:

  • To investigate the role of p54(nrb) in malignant melanoma.
  • To explore the relationship between MIA and p54(nrb) expression and function in melanoma.
  • To identify downstream targets of p54(nrb) in melanoma.

Main Methods:

  • Immunohistochemistry on melanoma cell lines and tissues.
  • Reporter assays to measure p54(nrb) promoter activity.
  • Small interfering RNA (siRNA) knockdown of MIA and p54(nrb).
  • Analysis of cell proliferation, migration, and attachment.
  • Quantitative analysis of Connexin-43 (Cx-43) mRNA and protein levels.

Main Results:

  • p54(nrb) exhibits high expression and nuclear localization in melanoma cells and tissues compared to normal melanocytes and skin.
  • MIA knockdown influences p54(nrb) expression at both mRNA and protein levels.
  • p54(nrb) knockdown reduces melanoma cell proliferation and migration while increasing attachment to laminin and poly-l-lysine.
  • Connexin-43 (Cx-43) is identified as a downstream target of p54(nrb), with its expression inversely correlated in melanoma cells versus melanocytes.

Conclusions:

  • p54(nrb) is significantly overexpressed in malignant melanoma.
  • MIA regulates p54(nrb) expression.
  • p54(nrb) plays a critical role in melanoma cell proliferation, migration, and potentially adhesion.
  • p54(nrb) influences the expression of Connexin-43, a molecule with altered levels in melanoma.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...